Sylvia Ernst

Sylvia Ernst has extensive experience in the pharmaceutical and biotech industry, particularly in drug discovery informatics. Sylvia started their career in 1994 as an Account Manager at MDL Information Systems Germany (Beilstein), where they sold software, services, and data to companies and academic institutions. Their role involved sales in Central Europe and Germany, with a focus on their flagship product, Beilstein CrossFire. Sylvia consistently exceeded sales quotas during their time at MDL.

In 1999, following the acquisition and merger of Beilstein GmbH into MDL and later MDL into Elsevier, Sylvia continued their role as an Account Manager before being promoted to Sales Manager in 2003. As Sales Manager Americas, they played a key role in creating a team of product sales managers to sell products from each portfolio of the merged companies. Sylvia collaborated extensively with sales organizations across the entities to drive sales growth.

In 2005, Sylvia joined SciTegic, a small company that became a key player in the drug discovery informatics field. As an Account Manager, they successfully sold their product, Pipeline Pilot, and consistently exceeded quotas, earning recognition as a member of the President's Club. SciTegic was later acquired by Accelrys, which merged with another company called Accelrys, where Sylvia continued their role as a Sr. Account Manager. Sylvia sold drug discovery informatics solutions, including Accelrys' product portfolio.

Finally, in 2007, Sylvia joined Collaborative Drug Discovery, Inc. as a Sr. Manager of Commercial Operations. Details about their role at this company are not provided.

Sylvia Ernst earned a Ph.D. in Chemistry from J.W. Goethe University in Frankfurt, Germany, completing their studies between 1985 and 1987. There is no available information about any further education they may have pursued.